| 1 |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394-424.
|
| 2 |
龙莉玲，彭鹏，黄仲奎. 原发性肝癌的早期影像学诊断[J]. 中华肝脏病杂志, 2017, 25(5): 329-332.
|
| 3 |
张伟，张建淮，祁付珍. 甲胎蛋白低浓度阳性肝细胞癌的早期诊断[J]. 医学综述, 2017, 23(17): 3383-3386.
|
| 4 |
梁群英，梁运霞，邱晓娣, 等. 肝穿刺行活体组织检查的临床病理分析[J]. 实验与检验医学, 2019, 37(4): 745-746, 750.
|
| 5 |
王志敏，金欢欢，卞勉励, 等. lncRNA在慢性肝病中的作用与机制研究进展[J]. 中国药理学通报, 2019, 35(8): 1037-1040.
|
| 6 |
Chen SL, Zhang YQ, Wu X, et al. Diagnostic value of lncRNAs as biomarker in hepatocellular carcinoma: an updated meta-analysis [J]. Can J Gastroenterol Hepatol, 2018: 8410195.
|
| 7 |
Zheng CQ, Liu XX, Chen LF, et al. lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis [J]. Oncotarget, 2017, 8(35): 59638-59647.
|
| 8 |
王秀月，赵川，陈彻, 等. 长链非编码RNA作为肝细胞癌诊断新型血清标志物的meta分析[J].中国癌症杂志, 2018, 28(3): 229-235.
|
| 9 |
Gao SB, Xu XH, Wang Y, et al. Diagnostic utility of plasma lncRNA small nucleolar RNA host gene 1 in patients with hepatocellular carcinoma [J]. Mol Med Rep, 2018, 18(3): 3305-3313.
|
| 10 |
杨哲锋，李娟，马志元, 等. 血浆LncRNA-HEIH表达水平与肝癌发病风险的关联分析[J]. 现代肿瘤医学, 2015, 23(1): 80-84.
|
| 11 |
Li J, Wang XC, Tang JW, et al. HULC and Linc00152 act as novel biomarkers in predicting diagnosis of hepatocellular carcinoma [J]. Cell Physiol Biochem, 2015, 37(2): 687-696.
|
| 12 |
Luo P, Liang CZ, Zhang XW, et al. Identification of long non-coding RNA ZFAS1as a novel biomarker for diagnosis of HCC [J]. Biosci Rep, 2018, 38(4): BSR20171359.
|
| 13 |
Wang K, Guo WX, Li N, et al. Serum LncRNAs profiles serve as novel potential biomarkers for the diagnosis of HBV-positive hepatocellular carcinoma [J]. PLoS One, 2015, 10(12): e0144934.
|
| 14 |
Wang ZF, Hu R, Pang JM, et al. Serum long noncoding RNA LRB1 as a potential biomarker for predicting the diagnosis and prognosis of human hepatocellular carcinoma [J]. Oncol Lett, 2018, 16(2): 1593-1601.
|
| 15 |
Zheng ZK, Pang C, Yang Y, et al. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma [J]. J Int Med Res, 2018, 46(1): 348-356.
|
| 16 |
Chao YJ, Zhou DJ. lncRNA-D16366 is a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma [J]. Med Sci Monit, 2019, 25: 6581-6586.
|
| 17 |
Bu HC, He DG, He XX, et al. Exosomes: isolation, analysis, and applications in cancer detection and therapy [J]. Chembiochem, 2019, 20(4): 451-461.
|
| 18 |
Li P, Kaslan M, Lee SH, et al. Progress in exosome isolation techniques [J]. Theranostics, 2017, 7(3): 789-804.
|
| 19 |
Lee YR, Kim G, Tak WY, et al. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma [J]. Int J Cancer, 2019, 144(6): 1444-1452.
|
| 20 |
Xu H, Chen YM, Dong XY, et al. Serum exosomal long noncoding RNAs ENSG00000258332.1 and LINC00635 for the diagnosis and prognosis of hepatocellular carcinoma [J]. Cancer Epidemiol Biomarkers Prev, 2018, 27(6): 710-716.
|
| 21 |
Sun L, Su YY, Liu XX, et al. Serum and exosome long non coding RNAs as potential biomarkers for hepatocellular carcinoma [J]. J Cancer, 2018, 9(15): 2631-2639.
|
| 22 |
Menke JM, Ahsan MS, Khoo SP. More accurate oral cancer screening with fewer salivary biomarkers [J]. Biomarkers Cancer, 2017, 9: 1179299X17732007.
|
| 23 |
Xie ZJ, Zhou FY, Yang YD, et al. Lnc-PCDH9-13:1 is a hypersensitive and specific biomarker for early hepatocellular carcinoma [J]. EBioMedicine, 2018, 33: 57-67.
|
| 24 |
Hu J, Wang NY, Yang YF, et al. Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma [J]. BMC Gastroenterol, 2018, 18(1): 186.
|
| 25 |
Liu X, Meng J, Xu HQ, et al. Alpha-fetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinoma [J]. Medicine (Baltimore), 2019, 98(17): e15414.
|
| 26 |
冯晓鸿，杜合娟. 脱-γ-羧基凝血酶原检测在早期肝细胞癌临床诊断中的价值[J]. 临床输血与检验, 2018, 20(2): 154-156.
|
| 27 |
Yu J, Han J, Zhang J, et al. The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis [J]. Medicine (Baltimore), 2016, 95(31): e4436.
|
| 28 |
Yuan WD, Sun Y, Liu L, et al. Circulating LncRNAs serve as diagnostic markers for hepatocellular carcinoma [J]. Cell Physiol Biochem, 2017, 44(1): 125-132.
|
| 29 |
Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? [J]. Cell, 2011, 146(3): 353-358.
|
| 30 |
Bai Y, Long JY, Liu ZS, et al. Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression [J]. J Cell Physiol, 2019, 234(10): 18837-18848.
|
| 31 |
Ye JX, Zhang JY, Lv YF, et al. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma [J]. J Cell Biochem, 2019, 120(8): 13810-13825.
|
| 32 |
Abd El Gwad A, Matboli M, El-Tawdi A, et al. Role of exosomal competing endogenous RNA in patients with hepatocellular carcinoma [J]. J Cell Biochem, 2018, 119(10): 8600-8610.
|